| Literature DB >> 32350355 |
Daisuke Sugita1, Hideaki Nakajima2, Yasuo Kokubo1, Naoto Takeura1, Takafumi Yayama3, Akihiko Matsumine1.
Abstract
The pathomechanisms of initiation and progression of ossification of the posterior longitudinal ligament (OPLL) are unclear. Indian hedgehog (Ihh) and related signaling molecules are key factors in normal enchondral ossification. The purpose of this study is to investigate the contribution of mechanical strain to OPLL and the relationship of Ihh with OPLL. Sections of the posterior longitudinal ligament (PLL) were obtained from 49 patients with OPLL and from 7 patients without OPLL. Cultured PLL cells were subjected to 24 hours of cyclic tensile strain. To identify differentially expressed genes associated with cyclic tensile strain, microarray analysis was performed. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis identified upregulation of various genes, particularly of the Hedgehog signaling pathway; Ihh and related genes had increased expression compared with controls after 24-hour cyclic tensile strain. In immunoblotting analysis, Ihh, Runx2, Sox9, Gli2, Gli3, and smoothened (SMO) had significantly increased expression after 6- or 12-hour cyclic tensile strain. OPLL samples were strongly immunopositive for Ihh, Sox9, Runx2, Gli2, Gli3, and SMO in the ossification front of OPLL. These results suggest that cyclic tensile strain induces abnormal activation of Ihh and related signaling molecules, and this might be important in the ossification process in OPLL.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32350355 PMCID: PMC7190672 DOI: 10.1038/s41598-020-64304-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic data for patients in the study.
| Case | Type of OPLL | Age/Sex | Most affected segment | Used for | ||
|---|---|---|---|---|---|---|
| OPLL | 1 | mixed | 59/M | C5–6 | cell culture | microarray immunoblotting |
| 2 | continuous | 68/M | C4–5 | microarray immunoblotting | ||
| 3 | mixed | 60/M | C5–6 | microarray | ||
| 4 | mixed | 71/M | C5–6 | immunoblotting | ||
| 5 | mixed | 75/M | C5–6 | immunoblotting | ||
| 6 | mixed | 68/M | C6–7 | immunoblotting | ||
| 7 | mixed | 63/F | C5–6 | immunoblotting | ||
| 8 | segmental | 79/M | C4–5 | immunoblotting | ||
| 9 | mixed | 73/F | C3–4 | immunoblotting | ||
| 10–49 | mixed (n = 12) continuous (n = 5) segmental (n = 23) | Ave. 69.9/ M (n = 23) F (n = 17) | C3–4 (n = 6), C4–5 (n = 11), C5–6 (n = 18), C6–7 (n = 5) | immunohistochemistry | ||
| Non-OPLL | 1 | CDH | 56/M | C4–5 | cell culture w/ or w/o immunohistochemistry | microarray immunoblotting |
| 2 | CDH | 60/M | C5–6 | microarray | ||
| 3 | CDH | 71/M | C5–6 | immunoblotting | ||
| 4 | CDH | 63/F | C4–5 | immunoblotting immunohistochemistry | ||
| 5 | CDH | 75/F | C4–5 | immunoblotting | ||
| 6 | CDH | 61/F | C5–6 | immunoblotting immunohistochemistry | ||
| 7 | CDH | 58/M | C5–6 | immunoblotting immunohistochemistry | ||
PLL: posterior longitudinal ligament.
OPLL: ossification of the posterior longitudinal ligament.
CDH: cervical disc herniation.
Figure 1ALP activity in non-stressed cultured spinal ligament cells. (A) non-OPLL cells. (B) OPLL cells. (C) Rates of ALP-positive cells (n = 3 each). *p < 0.05. Cultured spinal ligament cells from non-OPLL (D) or OPLL (E) patients exhibited a fibroblast-like, spindle-shaped appearance. (F) Green cells are live and red cells are dead in the Live and Dead assay. Scale bar = 50 μm. (G) Cyclic tensile strain for 24 hours did not change the morphological findings or the viability of the cultured cells (n = 3 each).
High frequency pathways identified by KEGG/pathway analysis for genes in OPLL cultured cells with expression changes >2.0-fold compared to those in non-OPLL cultured cells.
| Rank | Pathway | count | p-value |
|---|---|---|---|
| 1 | Influenza A | 22 | 0.0000043 |
| 2 | ECM-receptor interaction | 12 | 0.00058 |
| 3 | Herpes simplex infection | 18 | 0.00087 |
| 4 | Cell adhesion molecules (CAMs) | 15 | 0.0014 |
| 5 | Rheumatoid arthritis | 11 | 0.0023 |
| 6 | Focal adhesion | 18 | 0.0031 |
| 7 | Rap1 signaling pathway | 18 | 0.0038 |
| 8 | Inflammatory mediator regulation of TRP channels | 11 | 0.0051 |
| 8 | Measles | 13 | 0.0062 |
| 9 | Pathways in cancer | 27 | 0.0065 |
| 10 | Hedgehog signaling pathway | 7 | 0.0071 |
| 11 | Glycerolipid metabolism | 8 | 0.0075 |
| 12 | Malaria | 7 | 0.012 |
| 13 | Thyroid hormone signaling pathway | 11 | 0.015 |
| 14 | Phagosome | 13 | 0.015 |
| 15 | Hepatitis C | 12 | 0.016 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 8 | 0.016 |
| 17 | Epithelial cell signaling in Helicobacter pylori infection | 8 | 0.016 |
| 18 | Dilated cardiomyopathy | 9 | 0.017 |
| 19 | Natural killer cell mediated cytotoxicity | 11 | 0.022 |
| 20 | Toll-like receptor signaling pathway | 10 | 0.024 |
| 21 | Hepatitis B | 12 | 0.028 |
| 22 | ABC transporters | 6 | 0.029 |
| 23 | Long-term depression | 7 | 0.030 |
| 24 | Transcriptional misregulation in cancer | 13 | 0.032 |
| 25 | beta-Alanine metabolism | 5 | 0.033 |
| 26 | Hypertrophic cardiomyopathy (HCM) | 8 | 0.034 |
| 27 | Oxytocin signaling pathway | 12 | 0.035 |
| 28 | Leukocyte transendothelial migration | 10 | 0.038 |
| 29 | Ovarian steroidogenesis | 6 | 0.043 |
| 30 | Fc gamma R-mediated phagocytosis | 8 | 0.048 |
| 1 | Systemic lupus erythematosus | 22 | 0.000000036 |
| 2 | Alcoholism | 23 | 0.0000011 |
| 3 | Viral carcinogenesis | 18 | 0.0025 |
| 4 | Hypertrophic cardiomyopathy (HCM) | 10 | 0.0030 |
| 5 | Cell adhesion molecules (CAMs) | 14 | 0.0034 |
| 6 | ECM-receptor interaction | 10 | 0.0063 |
| 7 | Inflammatory mediator regulation of TRP channels | 10 | 0.013 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 8 | 0.015 |
| 9 | Dilated cardiomyopathy | 9 | 0.016 |
| 10 | Regulation of actin cytoskeleton | 16 | 0.016 |
| 11 | Influenza A | 14 | 0.017 |
| 12 | Legionellosis | 7 | 0.018 |
| 13 | MAPK signaling pathway | 18 | 0.019 |
| 14 | Oxytocin signaling pathway | 12 | 0.031 |
| 15 | Measles | 11 | 0.034 |
| 16 | Estrogen signaling pathway | 9 | 0.038 |
| 17 | p53 signaling pathway | 7 | 0.045 |
Genes related to Hedgehog signaling pathway analyzed by microarray.
| Gene | Accession number | OPLL | Non-OPLL | |||
|---|---|---|---|---|---|---|
| Ratioa (case 1) | Ratioa (case 2) | Ratioa (case 3) | Ratioa (case 1) | Ratioa (case 2) | ||
| Indian hedgehog (Ihh) | NM_002181 | 2.68 | 1.72 | 2.05 | 1.05 | 0.90 |
| Sox9 | NM_00346 | 10.81 | 1.18 | 1.28 | 1.96 | 1.35 |
| Runt-related gene2 (Runx2) | NM_004348 | 3.98 | 1.54 | 1.85 | 1.13 | 1.05 |
| Collagen type 11A2 (COL11A2) | NM_080680 | 3.91 | 1.20 | 1.75 | 0.62 | 0.75 |
| Collagen type 6a1 (COL6A1) | NM_001848 | 1.78 | 1.15 | 1.29 | 1.03 | 0.90 |
| Parathyroid hormone (PTH) | NM_000315 | 1.02 | 1.77 | 1.21 | 0.44 | 0.52 |
| Smoothened (SMO) | NM_005631 | 0.86 | 1.08 | 1.29 | 0.76 | 0.81 |
| Patched 1 (PTCH1) | NM_001083602 | 0.74 | 1.38 | 1.75 | 0.63 | 0.77 |
| Patched 2 (PTCH2) | NM_003738 | 1.16 | 0.81 | 1.31 | 0.73 | 0.90 |
| Sox5 | NM_152989 | 0.89 | 1.42 | 1.36 | 0.91 | 0.85 |
| Sox6 | NM_017508 | 10.12 | 2.52 | 3.49 | 0.89 | 0.80 |
| Gli2 | NM_005270 | 1.08 | 0.62 | 0.83 | 0.57 | 0.71 |
| Gli3 | NM_00168 | 1.20 | 1.48 | 2.24 | 0.85 | 0.80 |
| Vascular endothelial growth factor (VEGF) | NM_001025366 | 1.95 | 2.97 | 1.55 | 0.99 | 1.10 |
| Smad3 | NM_005902 | 1.06 | 0.67 | 0.51 | 0.38 | 0.49 |
| Bone morphogenetic protein2 (BMP2) | NM_001200 | 2.00 | 0.59 | 1.17 | 0.55 | 0.65 |
| Bone morphogenetic protein 4 (BMP4) | NM_001202 | 0.75 | 1.31 | 0.94 | 0.21 | 0.35 |
| Fibroblast growth factor receptor3 (FGFR3) | NM_00142 | 1.22 | 1.15 | 1.51 | 0.29 | 0.43 |
| Signal transducers and activator of transcription (STAT1) | NM_139266 | 0.62 | 1.18 | 1.08 | 0.87 | 0.82 |
| Serine /threonine protein kinase 36 (STK36) | NM_015690 | 1.36 | 1.26 | 1.74 | 0.71 | 0.93 |
Ratioa: the change in expression of each gene is shown as a ratio (24 hours/0 hour).
Figure 2Immunoblotting analysis of Ihh (A), Runx2 (B), Sox9 (C), Gli2 (D), Gli3 (E), and smoothened (SMO) (F). Relative band intensity normalized to that of β-actin. Ihh, Runx2, Sox9, Gli2, Gli3, and SMO increased significantly after 12-hour cyclic tensile strain in cells derived from patients with OPLL (OPLL cells, n = 8). There was no significant increase in each factors from patients without OPLL (non-OPLL cells, n = 6). *p < 0.05.
Figure 3(A,B) A section of OPLL had an expanding ossification front with abundant chondrocytes around the calcification front. A section of the non-OPLL posterior longitudinal ligament showing a regular arrangement of fiber bundles without a chondrometaplastic area. (A) H&E; (B) Toluidine blue. (C–H) Immunohistochemical staining of ossified posterior longitudinal ligament (OPLL) tissue. (C) Ihh is strongly expressed in proliferating chondrocytes. (D) Runx2 is expressed in proliferating chondrocytes in the fibrocartilage area. (E) Sox9 is strongly expressed in proliferating chondrocytes. (F) PTHrP is expressed in hypertrophic chondrocytes. (G) Gli2 is expressed in proliferating chondrocytes and cartilage matrix around the hypertrophic chondrocytes. (H) Gli3 is expressed in hypertrophic chondrocytes. Non-OPLL tissue are negative for each factor. Scale bar =100 μm. OA, ossified area; CCA, calcified cartilage area; FCA, fibrocartilage area.
Summary of immunohistochemical staining of the ossification front.
| Ossified area (OA) | Hypertrophic chondrocytes (CCA) | Proliferating chondrocytes (FCA) | Fiber area (FA) | |
|---|---|---|---|---|
| Ihh | ± | + | ++ | − |
| Runx2 | − | − | + | ± |
| Sox9 | ± | − | ++ | ± |
| PTHrP | − | + | ± | − |
| Gli2 | ± | + | + | − |
| Gli3 | − | + | ± | − |
++, strongly positive; +, moderately positive; ±, weakly positive; −, negative staining
OA, ossified area; CCA, calcified cartilage area; FCA, fibrocartilage area, FA, fiber area.